Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...
Source: marketscreener.com